Literature DB >> 3006027

Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.

M J Cowan, R O Brady, K J Widder.   

Abstract

Acquired immunodeficiency syndrome (AIDS) is an often fatal disease caused by a retrovirus frequently resulting in malignancy and/or opportunistic infection. Because the immune deficiency in AIDS is similar to that in some purine enzyme deficiencies, we measured erythrocyte adenosine deaminase (ADA) and purine nucleoside phosphorylase activities in patients with AIDS, heterosexual controls, and a high-risk asymptomatic population. We found that erythrocyte ADA activity was significantly elevated in patients with AIDS (40 +/- 11 nmol/mg of hemoglobin per hr, mean +/- SD) relative to heterosexual controls (25 +/- 10, P less than 0.001). We also measured ADA activity in a group of individuals at high risk for AIDS and found that approximately half had significantly elevated ADA activities (45 +/- 4, P less than 0.002) that correlated with the presence of antibody to the lymphadenopathy retrovirus. Purine nucleoside phosphorylase activity was relatively normal in patients with AIDS as well as in individuals at risk for AIDS. Increased ADA appears to be a diagnostic marker of AIDS and may be useful in conjunction with antibody to the AIDS-related retrovirus in detecting the presence of infection in asymptomatic high-risk individuals. These data also suggest that, in addition to the lymphocyte, the erythroid cell line may also be infected by the AIDS-related retrovirus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006027      PMCID: PMC323016          DOI: 10.1073/pnas.83.4.1089

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  SERUM ADENOSINE DEAMINASE IN THE DIFFERENTIAL DIAGNOSIS OF JAUNDICE.

Authors:  D M GOLDBERG
Journal:  Br Med J       Date:  1965-02-06

2.  Severe combined immunodeficiency with leukopenia (reticular dysgenesis) in siblings: immunologic and histopathologic findings.

Authors:  D R Ownby; S Pizzo; L Blackmon; S A Gall; R H Buckley
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

3.  Cytochemical markers of differentiation in acute leukemia.

Authors:  D Catovsky; L de Salvo Cardullo; M O'Brien; R Morilla; C Costello; D Galton; K Ganeshaguru; V Hoffbrand
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

Review 4.  Immunodeficiency syndromes associated with inherited metabolic disorders.

Authors:  M J Cowan; A J Ammann
Journal:  Clin Haematol       Date:  1981-02

5.  Purine salvage pathway enzyme activities in human T-, B-, and null lymphocyte populations.

Authors:  M J Cowan; M Fraga; J Andrew; N Laméris-Martin; A J Ammann
Journal:  Cell Immunol       Date:  1982-02       Impact factor: 4.868

6.  Cellular immune defect in selective IgA deficiency using a microculture method for PHA stimulation and limiting dilution.

Authors:  M J Cowan; P Fujiwara; A J Ammann
Journal:  Clin Immunol Immunopathol       Date:  1980-12

7.  A case of red-cell adenosine deaminase overproduction associated with hereditary hemolytic anemia found in Japan.

Authors:  S Miwa; H Fujii; N Matsumoto; T Nakatsuji; S Oda; H Asano; S Asano
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

8.  5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia.

Authors:  T A Sylwestrowicz; D D Ma; P P Murphy; M Massaia; H G Prentice; A V Hoffbrand; M F Greaves
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

9.  Acquired immune dysfunction in homosexual men: immunologic profiles.

Authors:  A J Ammann; D Abrams; M Conant; D Chudwin; M Cowan; P Volberding; B Lewis; C Casavant
Journal:  Clin Immunol Immunopathol       Date:  1983-06

10.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

View more
  9 in total

1.  Adenosine deaminase in cerebrospinal fluid of cerebral toxoplasmosis in AIDS.

Authors:  J Pedro-Botet; J C Soriano; S Tomás; R Miralles; J Rubiés-Prat
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

Review 2.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.

Authors:  Daniela F Passos; Viviane M Bernardes; Jean L G da Silva; Maria R C Schetinger; Daniela Bitencourt Rosa Leal
Journal:  Purinergic Signal       Date:  2018-08-10       Impact factor: 3.765

3.  Serum adenosine deaminase and total immunoglobulin G correlate with markers of immune activation and inversely with CD4 counts in asymptomatic, treatment-naive HIV infection.

Authors:  Hayley Ipp; Annalise E Zemlin; Richard H Glashoff; Johan van Wyk; Naadira Vanker; Tim Reid; Linda-Gail Bekker
Journal:  J Clin Immunol       Date:  2012-11-16       Impact factor: 8.317

4.  Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia.

Authors:  John H Fargo; Christian P Kratz; Neelam Giri; Sharon A Savage; Carolyn Wong; Karen Backer; Blanche P Alter; Bertil Glader
Journal:  Br J Haematol       Date:  2012-12-17       Impact factor: 6.998

5.  Hereditary overexpression of adenosine deaminase in erythrocytes: evidence for a cis-acting mutation.

Authors:  E H Chen; A P Tartaglia; B S Mitchell
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

6.  Adenosine deaminase mRNA expression is regulated posttranscriptionally during differentiation of HL-60 cells.

Authors:  T M Berkvens; F Schoute; H van Ormondt; P M Khan; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

7.  Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Authors:  José M Martinez-Navio; Núria Climent; Rodrigo Pacheco; Felipe Garcia; Montserrat Plana; Meritxell Nomdedeu; Harold Oliva; Cristina Rovira; Laia Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

8.  Serum adenosine deaminase activity in brain tumours.

Authors:  S Manjula; A Raja; S N Rao; A R Aroor; A Rao
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.

Authors:  F A Tausk; A McCutchan; P Spechko; R D Schreiber; I Gigli
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.